Navigation Links
A hands-on approach to treating patients with pulmonary disease
Date:8/14/2012

EAST LANSING, Mich. Researchers at Michigan State University are working to show how a noninvasive, drug-free form of hands-on medical care can help patients with chronic obstructive pulmonary disease improve their breathing.

The team from MSU's College of Osteopathic Medicine will apply four osteopathic manipulative treatments to a group of patients with moderate to severe chronic obstructive pulmonary disease. One of the most common lung diseases, COPD typically manifests as chronic bronchitis (a long-term cough with mucus) or emphysema (destruction of the lungs over time).

The goal, said lead researcher and associate professor Sherman Gorbis, is to attempt to determine the biochemical changes in patients' blood following osteopathic manipulation, a treatment where a physician uses his or her hands to diagnose and treat patients.

Osteopathic manipulative treatments have been used throughout the United States since the late 1800s. The techniques can be used to alleviate pain, restore range of motion and enhance the immune system.

However, Gorbis said, much of the evidence of the treatments' success has been anecdotal.

"That's what makes this project exciting," Gorbis said. "This will be one of the first studies to attempt to correlate treatment to pulmonary function and biochemical markers.

"If we can demonstrate that certain biochemical markers are enhanced with osteopathic manipulative treatment and show patients have increased pulmonary function, this could become a powerful teaching tool."

The study is being paid for with a nearly $100,000, two-year grant from the American Osteopathic Association in partnership with the Osteopathic Heritage Foundation.

The research team will recruit patients who have enrolled in McLaren-Greater Lansing Hospital's pulmonary rehabilitation program. As part of the trial, one group will undergo the osteopathic treatments, a second group will undergo a "sham treatment" that is hands-on but does not include manipulation and a third group will receive only the protocol normally part of the rehabilitation program with no hands-on treatment.

As patients join the trial, which will last 12 weeks for each enrollee, they will have blood drawn every two weeks. Those draws will be analyzed and measured. About 60 patients will take part over the two-year trial.

"By learning if certain biomarkers in the blood and plasma are enhanced in the group receiving the manipulation treatment, we hope to identify the physiological changes occurring among the patients," said Gorbis, who noted patients also will undergo exercise tolerance tests and complete questionnaires during the trial.

"While medication helps, there is no cure for COPD. But if we can improve the breathing process, and show how we are doing it, we can improve the quality of life of these patients."

Gorbis is working on the project with fellow osteopathic physicians Donald Sefcik, William Pintal and Aaron Bohrer, as well as fourth-year osteopathic medical student Kerry Melenovsky. Biochemists John Wang and Daniel Jones also are on the research team.

A successful pilot project will allow the team to seek funding from the National Institutes of Health to recruit larger numbers of patients in a multi-center trial.


'/>"/>

Contact: Jason Cody
codyja@msu.edu
517-432-0924
Michigan State University
Source:Eurekalert  

Related medicine news :

1. UH students spent summer making a difference with hands-on research
2. GWU consensus report outlines new approaches for evaluating benefits and risks of obesity drugs
3. Scripps Florida scientists awarded nearly $1.5 million to develop new approaches to treat cancer
4. MDC researchers develop new approach to treat acute liver failure
5. Phase III trial of dapivirine ring begins in Africa: New HIV prevention approach for women
6. Study implements community-based approach to treat HIV-infection in rural Uganda
7. Expert panel calls for new research approach to prevent youth violence
8. First-of-its-kind approach nanomedicine design effectively targets cancer with decreased toxicity
9. Researchers offer new approach to track former prisoners access to community HIV care
10. A better way to test new treatments? Approach could help patients and give useful results
11. Success of fertility treatment may approach natural birth rate
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A hands-on approach to treating patients with pulmonary disease
(Date:12/2/2016)... ... ... More than half of American teens report losing their virginity before they ... child about sex related topics, less than 60 percent spoke about deeper themes like ... launch of its second edition of the “Sexual Wellness” campaign, aiming to address the ...
(Date:12/2/2016)... ... December 02, 2016 , ... Universal Medical ... systems and the first company to offer robotic imaging to veterinary medicine is ... booth # 941 for the American Association of Equine Practitioners 62nd Annual Convention ...
(Date:12/2/2016)... Viejo, California (PRWEB) , ... December 02, 2016 , ... ... will allow FCPX editors to create versatile lower third titles with just a few ... , Pro3rd Accents Volume 2 includes 30 lower third animations. Choose from various styles ...
(Date:12/2/2016)... Pass, OR (PRWEB) , ... December 02, 2016 ... ... Wein, Medical Technologist/Clinical Laboratory Scientist & Author of Type 2 Diabetes: The Owner’s ... host of The Sharon Kleyne Hour Power of Water, Global Climate Change and ...
(Date:11/30/2016)... ... 2016 , ... "I hate when the mixture of saliva and toothpaste runs ... inventor from Bridgewater, N.J. "I thought that there had to be a way to ... the patent-pending DEFLECTOR to prevent saliva and toothpaste from running down the brush handle ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016 The U.S. Food and ... (empagliflozin) to reduce the risk of cardiovascular death in ... disease. "Cardiovascular disease is a leading ... mellitus," said Jean-Marc Guettier , M.D., C.M., director ... FDA,s Center for Drug Evaluation and Research. "Availability of ...
(Date:12/2/2016)... , December 2, 2016 Persistence ... pacemaker market in its upcoming report titled, "Global Market Study on ... Declining CAGR of -1.4% between 2016 and 2024". The global ... in 2015 and this is likely to decline to ... the global cardiac pacemaker market is anticipated to exhibit ...
(Date:12/2/2016)... NEW YORK , December 2, 2016 ... Market Research titled "Global Market Study on Automated Endoscope Reprocessors: ... Register a CAGR of 8.6% Between 2016 and 2024 " the ... 2015 and is expected to expand at a CAGR of ... market valuation of US$ 1,367.6 Mn by 2024. ...
Breaking Medicine Technology: